NCT06854809

Brief Summary

The objective of this clinical trial is to determine whether cognitive functional therapy is superior to therapeutic exercises for the treatment of chronic shoulder pain. The main questions it aims to answer are: Is cognitive functional therapy superior to therapeutic exercises for pain and disability in individuals with chronic shoulder pain? Is cognitive functional therapy superior to therapeutic exercises for functionality and psychosocial factors? Participants will: Receive 4 to 8 sessions of cognitive functional therapy once a week for four to eight weeks. Follow a therapeutic exercise protocol for eight weeks with a frequency of twice per week.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
148

participants targeted

Target at P75+ for not_applicable

Timeline
35mo left

Started Jul 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress23%
Jul 2025Mar 2029

First Submitted

Initial submission to the registry

February 25, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 3, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

July 1, 2025

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2029

Last Updated

June 18, 2025

Status Verified

June 1, 2025

Enrollment Period

1.9 years

First QC Date

February 25, 2025

Last Update Submit

June 13, 2025

Conditions

Keywords

shoulder painPsychosocial Rehabilitationexercise therapy

Outcome Measures

Primary Outcomes (2)

  • Pain intensity

    The intensity of shoulder pain will be assessed during arm movement in which the patient reports, pain using the Numeric pain rating scale (NPRS). The scale consists of an 11-point ordinal system, ranging from 0 to 10, where 0 represents no pain and 10 represents the worst possible pain.

    Baseline, 4-week, at the end of treatment (8-week), and 12-week follow-up

  • Shoulder disability

    Disability will be assessed using the Shoulder Pain and Disability Index (SPADI). The instrument is self-administered and consists of 13 items divided into 2 subscales (5 items for pain; 8 items for disability) and each item is scored from 0 to 10 points. The final score ranges from 0 to 100, with higher scores indicating greater shoulder disability.

    Baseline, 4-week, at the end of treatment (8-week), and 12-week follow-up

Secondary Outcomes (8)

  • Patient Specific Function

    Baseline, 4-week, at the end of treatment (8-week), and 12-week follow-up

  • Kinesiophobia

    Baseline, 4-week, at the end of treatment (8-week), and 12-week follow-up

  • Pain Self-Efficacy

    Baseline, 4-week, at the end of treatment (8-week), and 12-week follow-up

  • Sleep Quality

    Baseline, 4-week, at the end of treatment (8-week), and 12-week follow-up

  • Expectations with Treatment

    Baseline

  • +3 more secondary outcomes

Study Arms (2)

Cognitive functional therapy

EXPERIMENTAL
Behavioral: Cognitive functional therapy

Therapeutic exercise

ACTIVE COMPARATOR
Other: Therapeutic exercise

Interventions

The intervention consists of a Cognitive-Functional Therapy (CFT) program for individuals with shoulder pain, conducted by trained physiotherapists (106 hours of training) under the supervision of an expert with over 8 years of experience. CFT adopts a biopsychosocial approach and is structured into three main components: Making Sense of Pain - A cognitive component aimed at reinterpreting dysfunctional beliefs about pain through a reflective process based on the patient's life history, promoting understanding and self-efficacy. Graded Exposure with Control - Gradual exposure to functional activities, aiming to modify maladaptive associations between movement and pain, fostering the development of movement confidence. Lifestyle Change - Discussion and implementation of strategies to promote a healthy lifestyle, including physical activity, sleep habits, and stress management. All three components are integrated from the first session, with initial focus on building the therapeutic all.

Cognitive functional therapy

Participants in the Therapeutic Exercises Group will engage in individualized exercises targeting the scapulothoracic musculature and rotator cuff. The exercises, performed bilaterally, include lateral arm rotation, T, W, wall hand slide, and diagonal arm movement upwards. Each participant will be guided by one of two physiotherapists, randomly assigned. The exercises will follow a protocol consisting of 3 sets of 12 repetitions, with 1-minute rest between sets, using progressively resistant Thera-Bands®. Resistance will increase when pain is ≤2 on the Numerical Rating Scale and perceived exertion is \<3 on the Borg Scale. The protocol was designed based on scientific literature and shoulder pain treatment guidelines to address muscle activation deficits and rotator cuff and scapulothoracic imbalances.

Therapeutic exercise

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals of both sexes, aged between 18 and 65 years, will be included if they have had shoulder pain for at least 3 months and report a pain intensity of at least 3 points on the Numeric Pain Rating Scale (NPRS) at rest or during arm movement. Additionally, they must have a minimum score of 20 points on the Shoulder Pain and Disability Index (SPADI).

You may not qualify if:

  • Individuals will not be included if they have adhesive capsulitis, defined as a loss of more than 50% of passive shoulder range of motion in external rotation; previous shoulder surgery; a history of shoulder fracture; systemic musculoskeletal diseases (e.g., rheumatoid arthritis, fibromyalgia); shoulder pain reproduced by active or passive cervical spine movement; signs of glenohumeral instability identified by a positive sulcus test or a positive apprehension test indicating laxity in the glenohumeral joint; self-reported systemic disease; a positive drop arm test; pregnancy; active cancer treatment; neurological diseases; cognitive impairments; corticosteroid injection within three months prior to the intervention; or physical therapy in the three months preceding the study.
  • Participants will be discontinued from the study if they experience fractures, surgeries, musculoskeletal or neural injuries that prevent access to treatment, or receive corticosteroid injections during the treatment or follow-up period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidade Federal de Sao Carlos

São Carlos, São Paulo, 13568-110, Brazil

RECRUITING

MeSH Terms

Conditions

Shoulder Pain

Interventions

Exercise Therapy

Condition Hierarchy (Ancestors)

ArthralgiaJoint DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy Modalities

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Evaluators will be blinded to the treatment group
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a superiority randomized controlled trial, single-blinded, with two parallel groups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 25, 2025

First Posted

March 3, 2025

Study Start

July 1, 2025

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

March 1, 2029

Last Updated

June 18, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

The individual participant data will be shared under request.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
From December 1, 2027, to December 1, 2028, the data will be available for one year.
Access Criteria
The data will be shared with anyone who requests it via the responsible researcher's email.

Locations